Temat: liposomal - Katalog OPAC zbiorów

Skocz do pozycji: 1.

Tytuł:: Cytostatic treatment with irinotecan liposomal in a patient with advanced pancreatic adenocarcinoma
Autorzy:: Będkowski, Przemysław
Rogowski, Wojciech
Powiązania:: https://bibliotekanauki.pl/articles/2047206.pdf
Data publikacji:: 2021-06-30
Wydawca:: Medical Education
Tematy:: pancreatic adenocarcinoma
liposomal irinotecan
chemotherapy
Opis:: Pancreatic cancer is one of the most common malignant neoplasms with a short survival time and a low cure rate. This neoplasm progresses quickly, it is often diagnosed in the advanced stage, which means that systemic treatment regimens are not sufficiently effective. A case of 65-year-old patient with metastatic pancreatic cancer who underwent sequential chemotherapy with the use of liposomal irinotecan was presented.
Źródło:: OncoReview; 2021, 11, 2; 40-43
2450-6125
Pojawia się w:: OncoReview
Dostawca treści:: Biblioteka Nauki

Artykuł

Skocz do pozycji: 2.

Tytuł:: Prolongation of survival time and improvement of the quality of life after treatment with liposomal irinotecan in the patient with metastatic pancreatic adenocarcinoma
Autorzy:: Rogowski, Wojciech
Będkowski, Przemysław
Powiązania:: https://bibliotekanauki.pl/articles/2047214.pdf
Data publikacji:: 2021-07-15
Wydawca:: Medical Education
Tematy:: pancreatic cancer
chemotherapy
gemcitabine
liposomal irinotecan
Opis:: Pancreatic cancer is one of the malignant neoplasms with the worst prognosis. It is most often diagnosed at an advanced stage, which relates to unsatisfactory results of the therapy. Only about 15–20% of patients with pancreatic cancer qualify for surgery. The remaining patients are diagnosed with locally advanced disease or much more frequently in the generalized stage. Systemic treatment (chemotherapy) remains the mainstay of therapy in these patients, but both the response rate and progression-free time are unsatisfactory [1, 2]. This paper presents a case of a patient with metastatic pancreatic cancer, in whom three lines of systemic treatment were applied sequentially, which allowed to extend the survival time and improve the quality of life.
Źródło:: OncoReview; 2021, 11, 3; 77-79
2450-6125
Pojawia się w:: OncoReview
Dostawca treści:: Biblioteka Nauki

Artykuł

Informacja